These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 207726

  • 1. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW, Cooper B, Handin RI.
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [Abstract] [Full Text] [Related]

  • 2. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA.
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [Abstract] [Full Text] [Related]

  • 3. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F, Cazenave JP.
    Thromb Haemost; 1985 Aug 30; 54(2):402-8. PubMed ID: 3001964
    [Abstract] [Full Text] [Related]

  • 4. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
    Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ.
    J Clin Invest; 1978 Feb 30; 61(2):395-402. PubMed ID: 23392
    [Abstract] [Full Text] [Related]

  • 5. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG, O'Barr TP.
    Dev Pharmacol Ther; 1981 Feb 30; 2(4):215-25. PubMed ID: 6266790
    [Abstract] [Full Text] [Related]

  • 6. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT, Gore TB, Lefkowitz RJ.
    J Clin Invest; 1977 Feb 30; 59(2):319-24. PubMed ID: 13086
    [Abstract] [Full Text] [Related]

  • 7. Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.
    Carman-Krzan M.
    Arch Int Pharmacodyn Ther; 1980 Aug 30; 246(2):237-50. PubMed ID: 6254455
    [Abstract] [Full Text] [Related]

  • 8. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
    Williams LT, Snyderman R, Lefkowitz RJ.
    J Clin Invest; 1976 Jan 30; 57(1):149-55. PubMed ID: 1245597
    [Abstract] [Full Text] [Related]

  • 9. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE, Stump DC.
    Mol Pharmacol; 1982 Nov 30; 22(3):574-9. PubMed ID: 6296652
    [Abstract] [Full Text] [Related]

  • 10. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.
    Zatz M, Kebabian JW, Romero JA, Lefkowitz RJ, Axelrod J.
    J Pharmacol Exp Ther; 1976 Mar 30; 196(3):714-22. PubMed ID: 4608
    [Abstract] [Full Text] [Related]

  • 11. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
    Jakobs KH, Saur W, Schultz G.
    J Cyclic Nucleotide Res; 1976 Mar 30; 2(6):381-92. PubMed ID: 14175
    [Abstract] [Full Text] [Related]

  • 12. The alpha adrenergic response of Down's syndrome platelets.
    Sheppard JR, Schumacher W, White JG, Jakobs KH, Schultz G.
    J Pharmacol Exp Ther; 1983 Jun 30; 225(3):584-8. PubMed ID: 6306212
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B, Ahern D.
    J Clin Invest; 1979 Aug 30; 64(2):586-90. PubMed ID: 222813
    [Abstract] [Full Text] [Related]

  • 14. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F, Miyamoto K, Koshiura R.
    Cancer Res; 1989 Nov 15; 49(22):6242-6. PubMed ID: 2553251
    [Abstract] [Full Text] [Related]

  • 15. The effect of alpha and beta adrenergic receptor stimulation on the adenylate cyclase activity of human adipocytes.
    Burns TW, Langley PE.
    J Cyclic Nucleotide Res; 1975 Nov 15; 1(5):321-8. PubMed ID: 1225939
    [Abstract] [Full Text] [Related]

  • 16. Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.
    Williams LT, Mullikin D, Lefkowitz RJ.
    J Biol Chem; 1976 Nov 25; 251(22):6915-23. PubMed ID: 825511
    [Abstract] [Full Text] [Related]

  • 17. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    Lenox RH, Ellis J, Van Riper D, Ehrlich YH.
    Mol Pharmacol; 1985 Jan 25; 27(1):1-9. PubMed ID: 2981397
    [Abstract] [Full Text] [Related]

  • 18. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    Gerhardt MA, Wade SM, Neubig RR.
    Mol Pharmacol; 1990 Aug 25; 38(2):214-21. PubMed ID: 1974694
    [Abstract] [Full Text] [Related]

  • 19. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA, Johnston CI.
    Mol Pharmacol; 1982 Nov 25; 22(3):589-94. PubMed ID: 6296653
    [Abstract] [Full Text] [Related]

  • 20. Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil.
    Galant SP, Allred S.
    J Lab Clin Med; 1981 Aug 25; 98(2):227-37. PubMed ID: 6265572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.